chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Headache, Photophobia
Clinical narrative: Sensitivity to light; Headache; Head pressure; This is a spontaneous report from a contactable healthcare professional, the patient. A 25-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Aug2021 at 12:15 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. On 29Aug2021, the patient experienced sensitivity to light, headache and head pressure. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sensitivity to light, headache and head pressure were not resolved at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Asthenia, Hot flush, Hyperhidrosis, Lymphadenopathy
Clinical narrative: ongoing hot flashes; Sweating; anxiety; mood swings; Weakness; swollen lymph nodes; This is a spontaneous report from a contactable other healthcare professional, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 27Aug2021 at 09:15 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, von willebrand disease, chronic gastritis, polycystic ovarian syndrome (PCOS). The patient was allergic to penicillin, fish, strawberries and peanuts. The patient did not receive any medication within two weeks of vaccination. The patient previously took ibuprofen (MOTRIN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Aug2021 at 06:00, the patient had ongoing hot flashes, sweating, anxiety, mood swings, weakness and swollen lymph nodes. The hot flashes would not go away. She had never experienced this before the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events ongoing hot flashes, sweating, anxiety, mood swings, weakness and swollen lymph nodes was not recovered at the time of this report.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Mood swings
Clinical narrative: ongoing hot flashes; Sweating; anxiety; mood swings; Weakness; swollen lymph nodes; This is a spontaneous report from a contactable other healthcare professional, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 27Aug2021 at 09:15 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, von willebrand disease, chronic gastritis, polycystic ovarian syndrome (PCOS). The patient was allergic to penicillin, fish, strawberries and peanuts. The patient did not receive any medication within two weeks of vaccination. The patient previously took ibuprofen (MOTRIN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Aug2021 at 06:00, the patient had ongoing hot flashes, sweating, anxiety, mood swings, weakness and swollen lymph nodes. The hot flashes would not go away. She had never experienced this before the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events ongoing hot flashes, sweating, anxiety, mood swings, weakness and swollen lymph nodes was not recovered at the time of this report.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Chills, Dyspnoea, Fatigue, Headache
Clinical narrative: Severe pain next day left arm; Headache; Fatigue; Skin peeling near injection site; Chills, shivers; Burning sensation entire body; Itching; Rash; Difficulty breathing; Swelling at injection site to the point the band aid cut into the skin; Fever; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via an unspecified route of administration in the left arm on 31Aug2021 at 17:00 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included post-traumatic stress disorder (PTSD), fibromyalgia, scoliosis, chronic pain, hypermobility syndrome, allergic rhinitis, underweight, peanut allergy and allergy nos (unidentified). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included ascorbic acid/betacarotene/biotin/calcium carbonate/calcium pantothenate/chromic chloride/colecalciferol/cupric oxide/cyanocobalamin/dl-alpha tocopheryl acetate/ferrous fumarate/folic acid/magnesium oxide/manganese sulfate/nicotinamide/phytomenadione/pyridoxine hydrochloride/retinol acetate/riboflavin/sodium selenate/thiamine mononitrate/zinc oxide (ONE A DAY MULTIVITAMINS MINI GELS WOMEN'S) from an unknown date for unknown indication and unknown if ongoing. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) and azithromycin (AZO); both for unknown indications on unknown dates and experienced drug allergy. On 31Aug2021 at 19:00, the patient experienced skin peeling near injection site, chills, shivers, burning sensation entire body, itching, rash, difficulty breathing, swelling at injection site to the point the band aid cut into the skin, fever, severe pain next day (on 01Sep2021) in left arm, headache and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the reported events and included treatment with diphenhydramine hydrochloride (BENADRYL) and observation by special order (SO) and advice from nurse. The clinical outcome of the events skin peeling near injection site, chills, shivers, burning sensation entire body, itching, rash, difficulty breathing, swelling at injection site to the point the band aid cut into skin, fever, severe pain next day left arm, headache and fatigue was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Pyrexia, Rash, Skin exfoliation
Clinical narrative: Severe pain next day left arm; Headache; Fatigue; Skin peeling near injection site; Chills, shivers; Burning sensation entire body; Itching; Rash; Difficulty breathing; Swelling at injection site to the point the band aid cut into the skin; Fever; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via an unspecified route of administration in the left arm on 31Aug2021 at 17:00 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included post-traumatic stress disorder (PTSD), fibromyalgia, scoliosis, chronic pain, hypermobility syndrome, allergic rhinitis, underweight, peanut allergy and allergy nos (unidentified). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included ascorbic acid/betacarotene/biotin/calcium carbonate/calcium pantothenate/chromic chloride/colecalciferol/cupric oxide/cyanocobalamin/dl-alpha tocopheryl acetate/ferrous fumarate/folic acid/magnesium oxide/manganese sulfate/nicotinamide/phytomenadione/pyridoxine hydrochloride/retinol acetate/riboflavin/sodium selenate/thiamine mononitrate/zinc oxide (ONE A DAY MULTIVITAMINS MINI GELS WOMEN'S) from an unknown date for unknown indication and unknown if ongoing. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) and azithromycin (AZO); both for unknown indications on unknown dates and experienced drug allergy. On 31Aug2021 at 19:00, the patient experienced skin peeling near injection site, chills, shivers, burning sensation entire body, itching, rash, difficulty breathing, swelling at injection site to the point the band aid cut into the skin, fever, severe pain next day (on 01Sep2021) in left arm, headache and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the reported events and included treatment with diphenhydramine hydrochloride (BENADRYL) and observation by special order (SO) and advice from nurse. The clinical outcome of the events skin peeling near injection site, chills, shivers, burning sensation entire body, itching, rash, difficulty breathing, swelling at injection site to the point the band aid cut into skin, fever, severe pain next day left arm, headache and fatigue was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Severe pain next day left arm; Headache; Fatigue; Skin peeling near injection site; Chills, shivers; Burning sensation entire body; Itching; Rash; Difficulty breathing; Swelling at injection site to the point the band aid cut into the skin; Fever; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via an unspecified route of administration in the left arm on 31Aug2021 at 17:00 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included post-traumatic stress disorder (PTSD), fibromyalgia, scoliosis, chronic pain, hypermobility syndrome, allergic rhinitis, underweight, peanut allergy and allergy nos (unidentified). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included ascorbic acid/betacarotene/biotin/calcium carbonate/calcium pantothenate/chromic chloride/colecalciferol/cupric oxide/cyanocobalamin/dl-alpha tocopheryl acetate/ferrous fumarate/folic acid/magnesium oxide/manganese sulfate/nicotinamide/phytomenadione/pyridoxine hydrochloride/retinol acetate/riboflavin/sodium selenate/thiamine mononitrate/zinc oxide (ONE A DAY MULTIVITAMINS MINI GELS WOMEN'S) from an unknown date for unknown indication and unknown if ongoing. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) and azithromycin (AZO); both for unknown indications on unknown dates and experienced drug allergy. On 31Aug2021 at 19:00, the patient experienced skin peeling near injection site, chills, shivers, burning sensation entire body, itching, rash, difficulty breathing, swelling at injection site to the point the band aid cut into the skin, fever, severe pain next day (on 01Sep2021) in left arm, headache and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the reported events and included treatment with diphenhydramine hydrochloride (BENADRYL) and observation by special order (SO) and advice from nurse. The clinical outcome of the events skin peeling near injection site, chills, shivers, burning sensation entire body, itching, rash, difficulty breathing, swelling at injection site to the point the band aid cut into skin, fever, severe pain next day left arm, headache and fatigue was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Pain, Vaccination site pain
Clinical narrative: Day after second dose presented with sever muscle pain in vaccination arm; Pain is felt deep in muscle and radiates from injection site to elbow; Pain is felt deep in muscle and radiates from injection site to elbow; Severe muscle pain in vaccination arm; This is a spontaneous report from a contactable healthcare professional, the patient. A 67-year-old non-pregnant female patient received second dose of BNT162b2 (COMIRNATY; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 19Jun2021 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Information on concomitant medications were not available (N/A). The patient previously received the first dose (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8735) via an unspecified route of administration in the left arm on 29May2021 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. On 20Jun2021, the day after second dose, the patient presented with severe muscle pain in vaccination arm. Pain was felt deep in muscle and radiates from injection site to elbow side effect/adverse event was ongoing and presented when arm was lifted in any direction. She also reported that to do any task assistance from right arm is required. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events severe muscle pain in vaccination arm, pain was felt deep in muscle and radiates from injection site to elbow and day after second dose presented with sever muscle pain in vaccination arm were not resolved at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: A coin sticks to my arm like a magnet; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Aug2021 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 infection (prior to the vaccination, the patient was diagnosed with COVID-19). The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications. The patient did not have allergies to medications, food, or other products. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 01Sep2021, the patient reported that a coin sticks to her arm like a magnet. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event a coin sticks to arm like a magnet was recovering at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Dry mouth, Grip strength decreased, Muscular weakness, Tremor
Clinical narrative: Dry mouth shortly after the 1st shot and is still present; Weak arm- inability to carry and grip things roughly 5+ pounds in same arm the shot was administered.; Weak arm- inability to carry and grip things roughly 5+ pounds in same arm the shot was administered.; Also shaking of the arm and hand when carrying things for longer than 1-2 minutes.; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Aug2021 at 14:30 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Aug2021 at 15:00, shortly after the 1st shot, the patient experienced dry mouth and which was still present and weak arm- inability to carry and grip things roughly 5+ pounds in same arm the shot was administered and also shaking of the arm and hand when carrying things for longer than 1-2 minutes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event dry mouth, weak arm- inability to carry and grip things roughly 5+ pounds in same arm the shot was administered and also shaking of the arm and hand when carrying things for longer than 1-2 minutes was not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray, Cough, Oropharyngeal pain, Productive cough, Throat irritation
Clinical narrative: Productive cough (white sputum), excess mucous; Non-productive cough; Sore throat; Throat irritation; This is a spontaneous report from a contactable nurse, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0181) via an intramuscular route of administration in the right arm on 04Aug2021 at 16:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 05Aug2021, the patient experienced sore throat and throat irritation. On 06Aug2021, the patient experienced non-productive cough. On 18Aug2021, the patient experienced productive cough with white sputum, excess mucous and on 26Aug2021, the patient experienced productive cough with green/yellow sputum, excess mucous. The events resulted in doctors or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The patient underwent lab test which included chest X-ray on an unknown date in Aug2021 and the result was unknown. Therapeutic measures were taken as a result of events which included prednisone (MANUFACTURER UNKNOWN), tessalon perles (MANUFACTURER UNKNOWN) and azithromycin (MANUFACTURER UNKNOWN). The clinical outcome of the events sore throat, throat irritation, non-productive cough and productive cough with white sputum, excess mucous were not recovered at the time of the report.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Pain in extremity, Peripheral swelling, Pruritus
Clinical narrative: Pain, itching and swelling on left arm; Pain all across chest; Pain, itching and swelling on left arm; Pain, itching and swelling on left arm; This is a spontaneous report from a contactable healthcare professional. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 19Aug2021 at 07:15 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included heartburn. The patient had known allergies to spinach, cherry, cantaloupe, trees, and roaches. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient did not take any concomitant medications. On 19Aug2021 at 08:00, the patient experienced pain, itching, swelling on left arm and pain all across the chest for a week. The patient was not going to take any more dose. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of pain, itching and swelling on left arm were not recovered at the time of this report. The clinical outcome of pain all across chest was recovered on an unknown date in Aug2021.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Orthostatic hypotension, Pyrexia, SARS-CoV-2 test, Tachycardia
Clinical narrative: Migraine after 2nd vaccine that got progressively worse each day; Orthostatic hypotension; Mild fever; Tachycardia when standing; This is a spontaneous report from a contactable pharmacist, the patient. A 41-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Aug2021 at 15:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included bipolar II disorder, cerebrospinal fluid (CSF) leak, Hashimotos, Ehlers-Danlos syndrome (EDS) and sulfa allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lurasidone hydrochloride (LATUDA), levothyroxine (MANUFACTURER UNKNOWN), dexamfetamine sulfate/ amfetamine sulfate/ dexamfetamine saccharate/ amfetamine aspartate monohydrate (MYDAYIS), and fremanezumab (AJOVY); all for unknown indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Aug2021 at 15:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On 28Aug2021 at 20:30, the patient experienced migraine after second vaccine that got progressively worse each day, orthostatic hypotension, mild fever and tachycardia when standing. Since the vaccination, the patient had been tested for COVID-19. On 20Aug2021 and 24Aug2021, the patient underwent COVID test via nasal swab and the result were negative. Therapeutic measures were taken as a result of the events which included treatment with zolmitriptan (ZOMIG) and paracetamol (TYLENOL). The clinical outcome of the events migraine after second vaccine that got progressively worse each day, orthostatic hypotension, mild fever and tachycardia when standing were not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Gout
Clinical narrative: Gout left big toe; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Aug2021 at 10:45 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included unspecified birth control medication from an unknown date and unknown if ongoing. The patient previously received levofloxacin (LEVAQUIN) and prednisone (MANUFACTURER UNKNOWN) and experienced drug allergy. On 28Aug2021 at 14:00, the patient experienced gout left big toe. The event resulted in a visit to the doctors or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. It was unknown whether the patient received any treatment for the reported event. The clinical outcome of the event gout left big toe was not resolved at the time of the report. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Sep2021 at 09:45 (at the age of 49-year-old) as a single dose for COVID-19 immunisation.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Vision went blurry and couldnt see well for about 30 minutes; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 02Sep2021 at 11:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included escitalopram (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. On 02Sep2021 at 12:00, after about an hour after getting the shot, the patient's vision went blurry and could not see well for about 30 minutes. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event vision went blurry and couldn't see well for about 30 minutes was resolved on 02Sep2021 at 12:30.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3182) via an unspecified route of administration in the left arm on an unknown date in Aug2021 at 15:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included Epstein Barr virus (auto-immune) history years ago and allergic reactions to alcohol. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On an unknown date in Aug2021, the patient experienced headache every day since the day after the shot, it had been over 2 weeks at the time of report. The patient never had a history of headaches before. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event headache was unknown at the time of this report.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Back pain, Chills, Headache, Renal pain
Clinical narrative: Severe persistent stomach pain; Persistent kidney pain; Persistent lower back pain; Persistent headache; Persistent chills; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3182) via an unspecified route of administration in the left arm on 24Aug2021 at 13:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and pituitary adenoma. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine sodium (LEVOTHYROXIN) and cabergoline (MANUFACTURER UNKNOWN); both for unknown indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 03Aug2021 at 13:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. On 25Aug2021 at 12:00, the patient experienced severe persistent stomach pain, persistent kidney pain, persistent lower back pain, persistent headache and persistent chills. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe persistent stomach pain, persistent kidney pain, persistent lower back pain, persistent headache and persistent chills were not resolved at the time of this report.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain in extremity
Clinical narrative: Dull pain (blood clotting?)  in lower right leg, in calf area; Swelling in lymph nodes in armpits; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the right arm on 27Mar2021 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included breast feeding. The patient had recently stopped breastfeeding and otherwise the patient had no other changes or ongoing health issues. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included norethisterone (NORA-BE),  fish oil (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C) and women's multivitamin (unspecified); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the right arm on 06Mar2021 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. On an unknown date in 2021, immediately following the second vaccine, the patient experienced swelling in lymph nodes in armpits which subsided after 1-2 weeks. On 30Aug2021, the patient was experiencing dull pain (blood clotting?) in lower right leg, in calf area at the time of report. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling in lymph nodes in armpits and dull pain (blood clotting?) in lower right leg, in calf area were unknown at the time of the report.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood test, Computerised tomogram, Echoencephalogram, Electrocardiogram
Clinical narrative: headache; Numbness in arm; Joint pain; fatigue; fever; body aches; This is a spontaneous report from a contactable consumer (patient) via Pfizer Sponsored Program. A 51-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EW0180), intramuscular, administered in left arm on 20Jun2021 (at an unspecified age) as dose 1, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were none. Prior vaccinations were none. The patient experienced headache (hospitalization) on 21Jun2021, fever, body aches on 21Jun2021, Numbness in arm, Joint pain, fatigue on 22Jun2021. The patient underwent lab tests and procedures which included on 20Jul2021: Blood work: high sugar level, computerised tomogram (CT): normal, echoencephalogram (Echo): negative, electrocardiogram (EKG): negative, magnetic resonance imaging (MRI): normal, Covid-test: negative. The outcome of the events headache, numbness in arm, Joint pain, fatigue was not recovered, outcome of the other events was unknown.  Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hypoaesthesia, Magnetic resonance imaging, Pain
Clinical narrative: headache; Numbness in arm; Joint pain; fatigue; fever; body aches; This is a spontaneous report from a contactable consumer (patient) via Pfizer Sponsored Program. A 51-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EW0180), intramuscular, administered in left arm on 20Jun2021 (at an unspecified age) as dose 1, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were none. Prior vaccinations were none. The patient experienced headache (hospitalization) on 21Jun2021, fever, body aches on 21Jun2021, Numbness in arm, Joint pain, fatigue on 22Jun2021. The patient underwent lab tests and procedures which included on 20Jul2021: Blood work: high sugar level, computerised tomogram (CT): normal, echoencephalogram (Echo): negative, electrocardiogram (EKG): negative, magnetic resonance imaging (MRI): normal, Covid-test: negative. The outcome of the events headache, numbness in arm, Joint pain, fatigue was not recovered, outcome of the other events was unknown.  Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 antibody test
Clinical narrative: headache; Numbness in arm; Joint pain; fatigue; fever; body aches; This is a spontaneous report from a contactable consumer (patient) via Pfizer Sponsored Program. A 51-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EW0180), intramuscular, administered in left arm on 20Jun2021 (at an unspecified age) as dose 1, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were none. Prior vaccinations were none. The patient experienced headache (hospitalization) on 21Jun2021, fever, body aches on 21Jun2021, Numbness in arm, Joint pain, fatigue on 22Jun2021. The patient underwent lab tests and procedures which included on 20Jul2021: Blood work: high sugar level, computerised tomogram (CT): normal, echoencephalogram (Echo): negative, electrocardiogram (EKG): negative, magnetic resonance imaging (MRI): normal, Covid-test: negative. The outcome of the events headache, numbness in arm, Joint pain, fatigue was not recovered, outcome of the other events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Small rash on chest, upper back and right arm opposite arm from vaccination site; This is a spontaneous report from a contactable other healthcare professional, the patient. A 45-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 10Aug2021 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Aug2021, the patient experienced small rash on chest, upper back and right arm opposite arm from vaccination site. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event small rash on chest, upper back and right arm opposite arm from vaccination site was not resolved at the time of this report. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FP8448) via an unspecified route of administration in the left arm on 31Aug2021 (at the age of 45-years-old) as a single dose for COVID-19 immunisation.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, SARS-CoV-2 test
Clinical narrative: Racing heart; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 15Apr2021 at 15:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfa allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID) and estradiol (ESTROGEN) via topical and vaginal route of administration and more other medications (unspecified); all taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received influenza vaccine (flu shot) (MANUFACTURER UNKNOWN) in 2017 and experienced adverse reaction. On 15Apr2021 at 17:00, the patient experienced racing heart. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had been tested for COVID-19. On 26Aug2021, the patient underwent PCR test (nasal swab) and the result was negative. The clinical outcome of the event racing heart was resolved on an unknown date in 2021. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0168) via an unspecified route of administration in the left arm on 06May2021 at 15:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pain, Pain in extremity
Clinical narrative: Sore arm; Muscle tenderness; Achiness; Tired; This is a spontaneous report from a contactable healthcare professional, the patient. A 43-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3184) via an unspecified route of administration in the left arm on 03Sep2021 at 17:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, borderline anemia and COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19. The patient received unspecified concomitant medications. On 03Sep2021 at 18:00, the patient experienced sore arm, muscle tenderness, achiness and was tired. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events sore arm, muscle tenderness, achiness and tired were resolved on an unknown date in Sep2021.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Axillary pain
Clinical narrative: Lumps/soreness in armpit; Lumps/soreness in armpit; This is a spontaneous report from a contactable healthcare professional, the patient. A 30-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via an intramuscular route of administration in the right arm on 01Sep2021 at 15:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7484) via an intramuscular route of administration in the right arm on 11Aug2021 at 16:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. On 02Sep2021 at 10:00, the patient experienced lumps/soreness in armpit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events lumps/soreness in armpit were not resolved at the time of this report.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Dry mouth, Migraine
Clinical narrative: All over body and joint pain; Migraine; Dry mouth; Chills; Fever of 101.5 degrees; All over body and joint pain; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 03Sep2021 at 14:30 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergy to poppy seeds. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included loratadine (CLARITIN) and women's probiotic (unspecified); for unknown indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 13Aug2021 at 14:30 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient previously received sulfamethoxazole/trimethoprim (BACTRIM) and experienced drug allergy. On 04Sep2021 at 06:00, the patient experienced fever of 101.5 degrees, chills, all over body and joint pain, migraine and dry mouth. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever of 101.5 degrees, chills, all over body and joint pain, migraine and dry mouth were not resolved at the time of the report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: All over body and joint pain; Migraine; Dry mouth; Chills; Fever of 101.5 degrees; All over body and joint pain; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 03Sep2021 at 14:30 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergy to poppy seeds. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included loratadine (CLARITIN) and women's probiotic (unspecified); for unknown indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 13Aug2021 at 14:30 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient previously received sulfamethoxazole/trimethoprim (BACTRIM) and experienced drug allergy. On 04Sep2021 at 06:00, the patient experienced fever of 101.5 degrees, chills, all over body and joint pain, migraine and dry mouth. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever of 101.5 degrees, chills, all over body and joint pain, migraine and dry mouth were not resolved at the time of the report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Pain, Vomiting
Clinical narrative: Body aches; Vomiting; Explosive diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02Sep2021 at 14:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included seizure disorder and allergy to penicillin and grapefruit. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications. On 03Sep2021 at 12:00, the patient experienced body aches, vomiting and explosive diarrhea. Therapeutic measures were taken as a result of the event explosive diarrhea which included treatment with loperamide hydrochloride (IMODIUM). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches, vomiting and explosive diarrhea were resolved on an unknown date in Sep2021.   The lot number for BNT162b2 was not provided and will be requested during follow up.